An exosuit developed by Harvard University's Wyss Institute for Biologically Inspired Engineering has been shown to help facilitate normal walking ability for ambulatory patients following a stroke. The Restore exosuit is part of a study published in the July 26 edition of the Journal of Science Translational Medicine and included nine patients.

Myomo Inc. has received CE mark for its Myopro myoelectric arm orthosis wearable technology. The Cambridge, Mass.-based company said Myopro is a lightweight device that can restore function in the paralyzed or weakened arms and hands of individuals who have suffered a stroke, spinal cord or nerve injury, or other neuromuscular disability.

Accenture plc is using artificial intelligence to help visually impaired people improve the way they experience the world around them and enhance their productivity in the workplace. The Dublin-based company is testing the Drishti artificial intelligence solution in India. Drishti means "vision" in Sanskrit.

Senseonics Holdings Inc. has teamed up with Roche Diabetes Care Inc. and Typezero Technologies Inc. to develop a long-term automated insulin delivery system. The collaboration is part of the National Institutes of Health-funded International Diabetes Closed Loop (IDCL) multicenter trial, which was designed to test multiple automated insulin delivery systems.

Novarad Corp. is bringing the world of augmented reality (AR) into the operating room. Instead of looking at Pokemon, aliens or exotic locations – common staples of some augmented reality platforms – Salt Lake City-based Novarad is providing a personal look inside patients' bodies from the outside.